Lisanti Capital Growth’s CyrusOne Inc Common Stock CONE Stock Holding History

Lisanti Capital Growth’s Portfolio CONE Stock Details CONE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-14,065	Closed	-$669K	–	115
2016 Q3	$669K	Buy	14,065 +615	+5%	+$31.8K	0.85%	61
2016 Q2	$749K	Buy	+13,450	New	+$648K	1.13%	39

Other funds holding CONE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Brookfield Corp Toronto, Ontario, Canada $77B AUM 10.33% 1-Year Est. Return

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Lisanti Capital Growth's CONE Position: Q4 2016 in Review

Lisanti Capital Growth sold out of CyrusOne Inc Common Stock (CONE) in Q4 2016, closing a stake of 14,065 shares — an estimated $669K sold.

Lisanti Capital Growth first reported a position in CONE in Q2 2016 and held it in 2 quarters. The position peaked at $749K in Q2 2016. 277 funds tracked by Wall St. Rank hold CONE as of Q4 2016.

Lisanti Capital Growth reported no remaining CyrusOne Inc Common Stock position as of Q4 2016 after selling out during the quarter.
Lisanti Capital Growth sold 14,065 CyrusOne Inc Common Stock shares in Q4 2016, an estimated $669K.
Lisanti Capital Growth first reported a position in CyrusOne Inc Common Stock in Q2 2016 and held it in 2 quarters.
Lisanti Capital Growth's CyrusOne Inc Common Stock position peaked at $749K in Q2 2016.
277 funds tracked by Wall St. Rank held CyrusOne Inc Common Stock as of Q4 2016.

Based on Lisanti Capital Growth's 13F filing for Q4 2016, filed 26 Jan 2017.